5-aza-2'-deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome

Tamara L J Kelly1, En Li, Jacquetta M Trasler

  • 1Departments of Pediatrics, McGill University, and McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec, Canada.

Journal of Andrology
|October 29, 2003
PubMed

Insights

Paternal treatment with 5-aza-2'-deoxycytidine impacts mouse fertility and sperm DNA methylation. Lowering DNA methyltransferase 1 (DNMT1) levels partially mitigates these adverse effects on male germ cell development.

Area of Science:

  • Epigenetics
  • Reproductive Toxicology
  • Cancer Therapeutics

Background:

  • Cytidine analogues like 5-aza-2 eal-deoxycytidine are investigated for anticancer therapy due to their DNA hypomethylation effects.
  • The role of DNA methyltransferase 1 (DNMT1) in mediating these effects and potential impacts on male reproduction are not fully understood.

Purpose of the Study:

  • To investigate the effects of paternal 5-aza-2 eal-deoxycytidine exposure on mouse spermatogenesis and progeny outcomes.
  • To determine if reduced DNMT1 levels modulate the adverse effects of 5-aza-2 eal-deoxycytidine on male fertility.

Main Methods:

  • Adult male mice with wild-type (Dnmt1(+/+)) and deficient (Dnmt1(c/+)) DNMT1 levels were treated with varying doses of 5-aza-2 eal-deoxycytidine.
  • Evaluated testicular weight, sperm counts, histological abnormalities, and fertility parameters (pregnancy rate, preimplantation loss).
  • Assessed global DNA methylation levels in sperm DNA.

Main Results:

  • 5-aza-2 eal-deoxycytidine treatment caused dose-dependent decreases in testicular weight, increased abnormalities, and reduced sperm counts in wild-type mice.
  • Dnmt1-deficient mice showed less severe testicular effects compared to wild-type mice.
  • Paternal drug exposure reduced pregnancy rates and increased preimplantation loss; Dnmt1 deficiency partially protected against reduced pregnancy rates.

Conclusions:

  • Paternal 5-aza-2 eal-deoxycytidine administration impairs male germ cell development and fertility in mice, associated with decreased sperm DNA methylation.
  • Reduced DNMT1 levels offer partial protection to the seminiferous epithelium against the detrimental effects of 5-aza-2 eal-deoxycytidine.
  • These findings highlight potential reproductive risks associated with DNA-demethylating agents.

Related Concept Videos

Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Nondisjunction02:14

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.When...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...